NHS vs. NSTLX

Last updated Jun 5, 2026

NHS (Neuberger Berman High Yield Strategies Fund) and NSTLX (Neuberger Berman Strategic Income Fund) are both mutual funds - NHS is a High Yield Bonds fund actively managed by Neuberger Berman, while NSTLX is a Multisector Bonds fund managed by Neuberger Berman. Over the past 10 years, NHS returned 5.68%/yr vs 4.04%/yr for NSTLX. At a 0.25 correlation, their price movements are largely independent. NHS charges 4.14%/yr vs 0.59%/yr for NSTLX.

Performance

NHS vs. NSTLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neuberger Berman High Yield Strategies Fund (NHS) and Neuberger Berman Strategic Income Fund (NSTLX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NHS achieves a -7.75% return, which is significantly lower than NSTLX's 0.56% return. Over the past 10 years, NHS has outperformed NSTLX with an annualized return of 5.68%, while NSTLX has yielded a comparatively lower 4.04% annualized return.

NHS

• 1D: 0.95%
• 1M: 0.17%
• YTD: -7.75%
• 6M: -4.01%
• 1Y: -1.55%
• 3Y*: 8.86%
• 5Y*: -1.04%
• 10Y*: 5.68%

NSTLX

• 1D: -0.20%
• 1M: 0.36%
• YTD: 0.56%
• 6M: 0.92%
• 1Y: 6.18%
• 3Y*: 7.33%
• 5Y*: 2.73%
• 10Y*: 4.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NHS vs. NSTLX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NHS Neuberger Berman High Yield Strategies Fund	-7.75%	14.81%	11.04%	6.12%	-22.99%	15.78%	4.57%	39.03%	-11.45%	8.64%
NSTLX Neuberger Berman Strategic Income Fund	0.56%	9.44%	6.02%	10.07%	-11.81%	2.94%	7.78%	10.55%	-2.34%	7.00%

Correlation

The correlation between NHS and NSTLX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.31
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (5Y) Calculated over the trailing 5-year period	0.38
Correlation (10Y) Calculated over the trailing 10-year period	0.36
Correlation (All Time) Calculated using the full available price history since Jul 30, 2003	0.25

The correlation between NHS and NSTLX shifts across timeframes, from 0.25 (all time) to 0.38 (5 years), reflecting how their relationship changes across market environments.

Return for Risk

NHS vs. NSTLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NHS

NHS Risk / Return Rank: 2
NHS Sharpe Ratio Rank: 2
NHS Sortino Ratio Rank: 2
NHS Omega Ratio Rank: 2
NHS Calmar Ratio Rank: 2
NHS Martin Ratio Rank: 2

NSTLX

NSTLX Risk / Return Rank: 38
NSTLX Sharpe Ratio Rank: 41
NSTLX Sortino Ratio Rank: 46
NSTLX Omega Ratio Rank: 44
NSTLX Calmar Ratio Rank: 30
NSTLX Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NHS vs. NSTLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neuberger Berman High Yield Strategies Fund (NHS) and Neuberger Berman Strategic Income Fund (NSTLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NHS	NSTLX	Difference
Sharpe ratio: Return per unit of total volatility	-0.12	1.84	-1.96
Sortino ratio: Return per unit of downside risk	-0.08	2.86	-2.94
Omega ratio: Gain probability vs. loss probability	0.99	1.36	-0.37
Calmar ratio: Return relative to maximum drawdown	-0.09	2.02	-2.11
Martin ratio: Return relative to average drawdown	-0.23	7.35	-7.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NHS vs. NSTLX - Sharpe Ratio Comparison

The current NHS Sharpe Ratio is -0.12, which is lower than the NSTLX Sharpe Ratio of 1.84. The chart below compares the historical Sharpe Ratios of NHS and NSTLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NHS	NSTLX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.12	1.84	-1.96
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.06	0.54	-0.61
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.34	0.81	-0.47
Sharpe Ratio (All Time) Calculated using the full available price history	0.36	0.87	-0.51

Drawdowns

NHS vs. NSTLX - Drawdown Comparison

The maximum NHS drawdown since its inception was -64.67%, which is greater than NSTLX's maximum drawdown of -19.00%. Use the drawdown chart below to compare losses from any high point for NHS and NSTLX.

Drawdown Indicators

	NHS	NSTLX	Difference
Max Drawdown Largest peak-to-trough decline	-64.67%	-19.00%	-45.67%
Max Drawdown (1Y) Largest decline over 1 year	-17.01%	-3.30%	-13.71%
Max Drawdown (3Y) Largest decline over 3 years	-17.01%	-4.85%	-12.16%
Max Drawdown (5Y) Largest decline over 5 years	-37.43%	-16.65%	-20.78%
Max Drawdown (10Y) Largest decline over 10 years	-42.97%	-19.00%	-23.97%
Current Drawdown Current decline from peak	-13.32%	-1.06%	-12.26%
Average Drawdown Average peak-to-trough decline	-8.86%	-2.70%	-6.16%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.86%	0.90%	+5.96%

Volatility

NHS vs. NSTLX - Volatility Comparison

Neuberger Berman High Yield Strategies Fund (NHS) has a higher volatility of 3.17% compared to Neuberger Berman Strategic Income Fund (NSTLX) at 1.37%. This indicates that NHS's price experiences larger fluctuations and is considered to be riskier than NSTLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NHS	NSTLX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.17%	1.37%	+1.80%
Volatility (6M) Calculated over the trailing 6-month period	9.96%	2.88%	+7.08%
Volatility (1Y) Calculated over the trailing 1-year period	12.89%	3.62%	+9.27%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.17%	5.06%	+11.11%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.70%	4.99%	+11.71%

NHS vs. NSTLX - Expense Ratio Comparison

NHS has a 4.14% expense ratio, which is higher than NSTLX's 0.59% expense ratio.

Dividends

NHS vs. NSTLX - Dividend Comparison

NHS's dividend yield for the trailing twelve months is around 16.90%, more than NSTLX's 5.55% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NHS Neuberger Berman High Yield Strategies Fund	16.90%	14.60%	14.50%	13.94%	12.75%	8.74%	9.29%	7.99%	8.37%	7.59%	8.23%	9.81%
NSTLX Neuberger Berman Strategic Income Fund	5.55%	5.46%	5.31%	5.38%	3.92%	6.29%	3.81%	4.02%	4.33%	3.64%	3.54%	4.09%

Frequently Asked Questions

Can I hold both NHS and NSTLX in my portfolio?

NHS and NSTLX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, NHS or NSTLX?

NHS has higher volatility (3.17%) compared to NSTLX (1.37%). In terms of maximum drawdown, NHS dropped -64.67% vs NSTLX's -19.00%.

Which has better risk-adjusted returns?

NSTLX currently has the higher Sharpe Ratio (1.84 vs -0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.